Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 4
2013 1
2014 1
2015 1
2016 1
2017 1
2018 1
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy.
Zaborowska-Szmit M, Szmit S, Olszyna-Serementa M, Badurak P, Zajda K, Janowicz-Żebrowska A, Piórek A, Knetki-Wróblewska M, Jaśkiewicz P, Płużański A, Krzakowski M, Kowalski DM. Zaborowska-Szmit M, et al. Among authors: jaskiewicz p. Cancers (Basel). 2023 Feb 17;15(4):1277. doi: 10.3390/cancers15041277. Cancers (Basel). 2023. PMID: 36831618 Free PMC article.
Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03).
Grossi F, Jaśkiewicz P, Ferreira M, Czyżewicz G, Kowalski D, Ciuffreda L, Garcia-Gomez R, Caruso S, Bosch-Barrera J, Gautier S, Ta Thanh Minh C, Henriet S, de Castro G Jr. Grossi F, et al. Among authors: jaskiewicz p. Ther Adv Med Oncol. 2021 Jul 16;13:17588359211022905. doi: 10.1177/17588359211022905. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34349841 Free PMC article.
[Gefitinib in patients with advanced non-small-cell lung cancer].
Knetki-Wróblewska M, Kowalski DM, Zajda K, Płużański A, Badurak P, Janowicz-Żebrowska A, Jaśkiewicz P, Krzakowski M. Knetki-Wróblewska M, et al. Among authors: jaskiewicz p. Pneumonol Alergol Pol. 2012;80(5):439-49. Pneumonol Alergol Pol. 2012. PMID: 22926905 Free article. Polish.
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial.
Schuler M, Yang JC, Park K, Kim JH, Bennouna J, Chen YM, Chouaid C, De Marinis F, Feng JF, Grossi F, Kim DW, Liu X, Lu S, Strausz J, Vinnyk Y, Wiewrodt R, Zhou C, Wang B, Chand VK, Planchard D; LUX-Lung 5 Investigators. Schuler M, et al. Ann Oncol. 2016 Mar;27(3):417-23. doi: 10.1093/annonc/mdv597. Epub 2015 Dec 8. Ann Oncol. 2016. PMID: 26646759 Free PMC article. Clinical Trial.
12 results